Inhibition of mevalonate 5-pyrophosphate decarboxylase by a proline-containing transition state analog

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 17, 1996, Pages 2091-2096

  Vlattas, Isidores ^a   Dellureficio, James ^a   Ku, Edmund ^a   Bohacek, Regine ^a   Zhang, Xiaolu ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CARBOXYLYASE; DIPHOSPHOMEVALONATE DECARBOXYLASE; PROLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; NUCLEAR MAGNETIC RESONANCE;

EID: 0030567852     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00374-5     Document Type: Article

References (25)

1. Qureshi, N.; Porter, J. W. Biosynthesis of Isoprenoid Compounds; Porter J. W., Spurgeon, S. L. Eds. John Wiley and sons, New York. Vol 1, pp 47-94.
2. Richards J. H.; Hendrickson J. B. The Biosynthesis of Steroids, Terpenes and Acetogenins; Benjamin, New York, 1964.
3. Bach, J. T. JAOCS 1988, 65, 591.
4. Jabalquinto, A. M.; Alvear, M.; Cardemil, E. Comp. Biochem. Physiol. 1988, 90B, 671.
5. Tavormina P. A.; Gibbs, M. H.; Huff, J. W. J. Am. Chem. Soc. 1956, 78, 4498.
6. Stewart, J. M.; Woolley D. W. Biochemistry 1964, 3, 1998, and references therein.
7. Singer, F. M.; Januszka, J. P.; Borman, A. Proc. Soc. Exp. Biol. Med. 1959, 102, 370.
8. Quistad, G. B.; Cerf, D. C.; Schooley, D. A.; Staal, G. B. Nature (London) 1981, 289, 176.
9. Cuthbert, J.A.; Lipsky, P.E. Cancer Research 1995, 55, 1732.
10. Nave, J-F.; d'Orchymont, H.; Ducep, J-B.; Piriou, F.; Jung, M.J. Biochem. J. 1985, 227, 247.
11. Dhe-Paganon, S.; Magrath, J.; Abeles, R. H. Biochemistry 1994, 33, 13355
12. Cini, R.; Sabat, M.; Sundaraligam M.; Burba, M. C.; Nunzi, A.; Polidori, G.; Zanazzi, P. F. J. Biomolecular Structure and Dynamics 1983, 1, 633.
13. McMartin, C.; Bohacek, R. J. Compt. Aided Mol. Design 1995, 9, 237.
14. 15 Compounds 1, 2, and 4 a-c were isolated as amorphous powders of tetralithium salts and exhibited satisfactory analytical data (±0.4% for C, H, and N).
15. Woodside, B. A.; Huang, Z.; Poulter, C. D. Org. Syntheses 1988, 66, 211.
16. 14C] IPP.
17. Alvear, M.; Jabalquinto, A. M.; Eyzaguirre, J.; Cardemil, E. Biochemistry 1982, 21, 4646.
18. Rose, G. D.; Gierasch, L. M.; Smith, J. A. Adv. Protein Chem. 1985, 37, 1.
19. Montelione, G. T.; Arnold, E.; Meinwald, Y. C.; Stimson, E. R.; Denton, J. B.; Huang, S. G.; Clardy, J.; Scheraga, H. A. J. Am. Chem. Soc. 1984, 106, 7946.
20. Dyson, H. J.; Rance, M.; Houghten, R. A.; Lerner, R. A.; Wright, P. E.; J. Mol. Biol. 1988, 201, 161.
21. Imperiali, B.; Fisher, S. L.; Moata, R. A.; Prins, T. J. J. Am. Chem. Soc. 1992, 114, 3182.
22. Yao. J.; Brüischweiler, R.; Dyson, H. J.; Wright, P. E. J. Am. Chem. Soc. 1994, 116, 12051.
23. pp = 20.002, β-P).
24. Bothner - By, A. A.; Stephens, R. L.; Lee, J.; Warren, C. D.; Jeanloz, R. W. J. Am. Chem. Soc. 1984, 106, 811.
25. Thomas, W. A.; Williams, M. K. J. C. S. Chem. Comm. 1972, 994.